Correlation analysis revealed a positive association between CD29 and FOXP3 in HCC patients, suggesting a mechanistic link whereby CD29+ Tregs promote HCC progression via CD29 upregulation. This evidence concerns the gene FOXP3 and hepatocellular carcinoma.